Physician profile
Michael William Roberts
NPI 1508062803
$1,971.94
in general payments reported to CMS, 2019-2025
12 companies · $369 in 2025
The $369 reported for 2025 was more than what 89% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $507 · 2020: $61.62 · 2021: $206 · 2022: $270 · 2023: $307 · 2024: $251 · 2025: $369.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $927.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $927.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $840.69 | 2020-2025 | Amplatzer Amulet, Supera, Aveir |
| Boston Scientific Corporation | $413.80 | 2019-2025 | Eluvia, Angiojet Ultra 5000a, Ekosonic |
| Merck Sharp & Dohme LLC | $406.58 | 2019-2025 | Bridion |
| Vertex Pharmaceuticals Incorporated | $111.73 | 2025 | |
| Novartis Pharmaceuticals Corporation | $44.24 | 2019-2020 | |
| La Jolla Pharmaceutical Company | $35.13 | 2019 | |
| Siemens Medical Solutions USA, INC. | $28.90 | 2024-2025 | Artis Icono Floor |
| Pacira Pharmaceuticals Incorporated | $21.24 | 2019 | |
| Covidien LP | $19.48 | 2019 | |
| Mallinckrodt Enterprises LLC | $17.45 | 2019 | |
| Abbvie INC. | $16.37 | 2019 | |
| Chiesi USA, INC. | $16.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Roberts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.